Lee, C. R. (2018). Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention [Original Articles]. American Heart Association (AHA).
Chicago Style (17th ed.) CitationLee, C. R. Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention [Original Articles]. American Heart Association (AHA), 2018.
MLA (9th ed.) CitationLee, C. R. Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention [Original Articles]. American Heart Association (AHA), 2018.
Warning: These citations may not always be 100% accurate.